Efficacy and safety of paclitaxel/ramucirumab as the second-line chemotherapy in Japanese patients with advanced gastric cancer.

被引：1
|
作者：
Kusumoto, Tetsuya
Egashira, Akinori
Sonoda, Hideto
Hashimoto, Kenkichi
Uehara, Hideo
Kusumoto, Eiji
Shinzato, Chiaki
Uchino, Keita
Sakaguchi, Yoshihisa
Ikejiri, Koji
Maehara, Yoshihiko
机构：
[1] Natl Kyushu Med Ctr, Dept Gastrointestinal Surg, Fukuoka, Fukuoka, Japan
[2] Natl Kyushu Med Ctr, Clin Res Ctr Canc Res Div, Fukuoka, Fukuoka, Japan
[3] Natl Kyusyu Med Ctr, Dept Med Oncol, Fukuoka, Fukuoka, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15540
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15540
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Ishikawa, Masashi
    Iwasa, Satoru
    Nagashima, Kengo
    Aoki, Masahiko
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Saruta, Masayuki
    Boku, Narikazu
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 533 - 540
  • [32] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Masashi Ishikawa
    Satoru Iwasa
    Kengo Nagashima
    Masahiko Aoki
    Hiroshi Imazeki
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Masayuki Saruta
    Narikazu Boku
    Investigational New Drugs, 2020, 38 : 533 - 540
  • [33] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Ji, Sang Hoon
    Lim, Do Hyoung
    Yi, Seong Yoon
    Kim, Hyo Song
    Jun, Hyun Jung
    Kim, Kyoung Ha
    Chang, Myung Hee
    Park, Min Jae
    Uhm, Ji Eun
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    BMC CANCER, 2009, 9
  • [34] Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases
    Soga, Norihito
    Onishi, Takehisa
    Arima, Kiminobu
    Sugimura, Yoshiki
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (09) : 828 - 832
  • [35] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Sang Hoon Ji
    Do Hyoung Lim
    Seong Yoon Yi
    Hyo Song Kim
    Hyun Jung Jun
    Kyoung Ha Kim
    Myung Hee Chang
    Min Jae Park
    Ji Eun Uhm
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    BMC Cancer, 9
  • [36] Second-line chemotherapy for advanced gastric cancer in Korea
    Sun Kyung Baek
    Si-Young Kim
    Jae-heon Jeong
    Kyung San Cho
    Hwi-Joong Yoon
    Gastric Cancer, 2012, 15 : 345 - 354
  • [37] Second-line chemotherapy for advanced gastric cancer in Korea
    Baek, Sun Kyung
    Kim, Si-Young
    Jeong, Jae-Heon
    Cho, Kyung San
    Yoon, Hwi-Joong
    GASTRIC CANCER, 2012, 15 (04) : 345 - 354
  • [38] Is there a role for second-line chemotherapy in advanced gastric cancer?
    Wesolowski, Robert
    Lee, Chan
    Kim, Richard
    LANCET ONCOLOGY, 2009, 10 (09): : 903 - 912
  • [39] Correlation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy
    Roviello, Giandomenico
    Martina, Catalano
    Winchler, Costanza
    Aquino, Irene De Gennaro
    Papa, Francesca
    Buttitta, Eleonora
    Rossi, Gemma
    Antonuzzo, Lorenzo
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (03) : 802 - 808
  • [40] Chemotherapy beyond second-line in advanced gastric cancer
    Sung Min Kim
    Se Hoon Park
    World Journal of Gastroenterology, 2015, (29) : 8811 - 8816
12345